|
Market Closed -
London S.E.
16:35:14 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 12,824.00 GBX | -1.20% |
|
+3.04% | -7.01% |
| 07:00pm | Takeda to seek Japan approval for gastric cancer drug next year | RE |
| 06:16pm | AstraZeneca's stomach cancer drug extends overall survival, late-stage trial data finds | RE |
ETFs positioned on AstraZeneca PLC
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +10.00% | - | 27,154 M€ | |
| +10.07% | - | 2,627 M€ | |
| -.--% | - | 22 M€ | |
| +0.69% | - | 51 M€ | |
| +12.13% | - | 122 M€ | |
| +1.23% | - | 293 M€ | |
| +9.68% | - | 3,469 M€ | |
| +7.22% | - | 6,576 M€ | |
| +6.68% | 17.21% | 391 M€ | |
| +6.73% | 15.79% | 1,024 M€ | |
| +4.51% | 15.25% | 820 M€ | |
| +7.25% | 13.81% | 667 M€ | |
| +6.82% | 9.6% | 106 M€ | |
| +7.46% | 9.6% | 147 M€ | |
| +5.68% | 9.6% | 19 M€ | |
| +10.34% | 9.6% | 1,166 M€ | |
| +10.41% | 9.5% | 2,462 M€ | |
| +6.50% | 9.5% | 428 M€ | |
| +10.78% | 9.32% | 158 M€ | |
| +10.32% | 9.22% | 265 M€ | |
| +8.56% | 9.07% | 935 M€ | |
| -.--% | 8.9% | 1,190 M€ | |
| +7.10% | 8.9% | 1,190 M€ | |
| +12.33% | 8.88% | 38 M€ | |
| +7.00% | 8.88% | 90 M€ | |
| +9.04% | 8.7% | 679 M€ | |
| +10.35% | 8.68% | 1,211 M€ | |
| +7.49% | 8.64% | 44 M€ | |
| +8.05% | 8.6% | 3,929 M€ | |
| +7.08% | 8.58% | 6,358 M€ | |
| -.--% | 8.57% | 122 M€ | |
| +10.53% | 8.57% | 122 M€ | |
| +10.10% | 8.56% | 4,353 M€ | |
| +10.28% | 8.56% | 225 M€ | |
| +9.18% | 8.53% | 54 M€ | |
| +6.35% | 8.39% | 56 M€ | |
| +11.66% | 8.3% | 19 M€ | |
| -.--% | 8.11% | 114 M€ | |
| +11.53% | 8.11% | 114 M€ | |
| +7.53% | 7.88% | 158 M€ | |
| +11.91% | 7.83% | 97 M€ | |
| +11.98% | 7.57% | 22,220 M€ | |
| +10.38% | 7.55% | 544 M€ |
Employees
96,100
Sector
Pharmaceuticals
Calendar
- Stock Market
- Stocks
- AZN Stock
- ETFs AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
